Toronto, May 25, 2026, 15:01 (EDT)
- Xanadu’s TSX-listed shares were quoted at C$21.85, up 5.18%, while its Nasdaq line was shut for Memorial Day after closing Friday at $15.18.
- The company last week announced a $300 million equity facility and a quantum-memory advance it said could cut a costly operation by roughly half.
- Investors head into the week watching dilution risk, government-backed rivals and Xanadu’s May 28 TD Cowen meetings.
Xanadu Quantum Technologies’ Toronto-listed shares rose on Monday, giving investors a live read on the newly public quantum computing company while its Nasdaq listing sat out the U.S. Memorial Day holiday. TradingView showed the TSX stock at C$21.85, up 5.18%; Nasdaq’s 2026 calendar lists May 25 as a closed session.
The Nasdaq-listed shares last traded at $15.18 on Friday, up 5.05%, TMX Money data showed. That split-market day matters because Xanadu spent last week giving investors two things to price at once: more possible capital and a technical claim on lowering quantum-computing costs.
The Toronto company, listed on both Nasdaq and the TSX under XNDU, said on May 21 it had entered a synthetic at-the-market equity facility of up to $300 million with Yorkville Advisors. An at-the-market facility lets a company sell new shares over time, rather than in one block, and Xanadu said it had the ability but not the obligation to issue Class B subordinate voting shares over three years.
Chief Financial Officer Michael Trzupek said the program gives Xanadu “efficient and flexible access to capital” as it scales its roadmap toward fault-tolerant quantum computing. The company said proceeds, if any, would be used for working capital and general corporate purposes. Xanadu Quantum Technologies Limited
On the same day, Xanadu announced an advance in quantum read-only memory, or QROM, a method for loading ordinary data into a quantum computer. The company said the work could cut the number of costly Toffoli gates — expensive quantum operations — by about half in QROM modules.
Founder and Chief Executive Christian Weedbrook said Xanadu was trying to make quantum computing “practical for real-world use.” The claim is still technical, but it goes to the point investors care about most: whether quantum machines can move from lab promise to useful commercial systems. Xanadu Quantum Technologies Limited
The money question is not theoretical. Xanadu reported first-quarter revenue of $2.8 million, up fourfold from a year earlier, but its net loss widened to $20.6 million from $12.2 million. Cash and equivalents stood at $272.5 million at March 31.
Xanadu also reported an adjusted EBITDA loss of $13.9 million. Adjusted EBITDA is a company-defined profit measure that strips out items such as interest, taxes, depreciation and amortization; here, it remains a loss measure, not cash generation.
The broader Canadian tape helped. Canada’s S&P/TSX composite hit a record high on Monday, rising 0.7% by late morning as materials stocks climbed and oil fell, Reuters reported. Brian Madden, chief investment officer at First Avenue Investment Counsel, said markets were reacting to U.S.-Iran peace hopes, though he was “not 100% convinced this is the real deal.” Reuters
The competitive backdrop is getting heavier. Reuters reported last week that the U.S. government planned $2 billion in equity stakes across quantum-computing companies, including IBM and support for firms such as D-Wave, Rigetti Computing and Infleqtion. Infleqtion CEO Matthew Kinsella told Reuters the investment suggested quantum computing was “coming much faster than anybody thinks.” Reuters
Xanadu was not named in that Reuters list, but the move raises the bar for the sector. It puts public money and strategic attention behind several peers just as Xanadu is trying to sell investors on a photonic approach, which uses light-based systems and is designed to compute at room temperature.
The week ahead gives management another chance to frame the story. Xanadu is scheduled for individual meetings at TD Cowen’s 54th Annual Technology, Media & Telecom Conference in New York on May 28.
But the downside case is plain. Xanadu itself warned that the program could cause substantial dilution and that sales, or even the perception of sales, could pressure the share price; it also cited technical challenges, limited operating history and the risk that commercialization may not arrive on the expected timetable.
